TD Asset Management »

Ascendis Pharma AS shares owned by TD Asset Management

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by TD Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $32M 119k 266.72

More positions owned by TD Asset Management

NVIDIA Corporation (NVDA)
Rbc Cad (RY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Bank Of Montreal Cadcom (BMO)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Cibc Cad (CM)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Enbridge (ENB)
Amazon (AMZN)
Manulife Finl Corp (MFC)
Canadian Pacific Kansas City (CP)
Johnson & Johnson (JNJ)

View all positions for TD Asset Management

Top funds holding Ascendis Pharma AS

T. Rowe Price Associates
Principal Financial Group
Bank of New York Mellon
Pictet Asset Management Holding SA
A.R. Schmeidler & Co
New York State Common Retirement Fund
Stacey Braun Associates
Walleye Trading Advisors
Driehaus Capital Management
TD Asset Management
Fiera Capital Corporation
Q Global Advisors
Sapient Capital
Walleye Trading
Russell Investments

View all funds holding Ascendis Pharma AS